Adoption of single-use systems and more flexible systems drive innovation.
May 22, 2013
By:
Cynthia Challener, PhD
Adoption of single-use systems and more flexible systems drive innovation.
|
The growing demand for targeted biopharmaceutical therapies is driving interest in modular production facilities that can be rapidly constructed while still minimizing risk and cost.
May 22, 2013
By:
Cynthia Challener, PhD
The growing demand for targeted biopharmaceutical therapies is driving interest in modular production facilities that can be rapidly constructed while still minimizing risk and cost.
|
Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.
May 22, 2013
By:
Cynthia Challener, PhD
Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.
|
Greater automation and the adoption of solid versus perforated pans are some recent advances.
May 22, 2013
By:
Cynthia Challener, PhD
Greater automation and the adoption of solid versus perforated pans are some recent advances.
|
Access to extremely low and consistently controlled reaction temperatures can improve product yields and selectivities while also reducing costs.
May 22, 2013
By:
Cynthia Challener, PhD
Access to extremely low and consistently controlled reaction temperatures can improve product yields and selectivities while also reducing costs.
|
Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost.
May 8, 2013
By:
Cynthia Challener, PhD
Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost.
|
New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.
May 8, 2013
By:
Cynthia Challener, PhD
New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.
|
Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.
May 8, 2013
By:
Cynthia Challener, PhD
Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.
|
New ion-exchange chromatography media are more tolerant of varying conditions, making it possible to eliminate process steps.
May 8, 2013
By:
Cynthia Challener, PhD
New ion-exchange chromatography media are more tolerant of varying conditions, making it possible to eliminate process steps.
|
|
